Publication

A beta 42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Related publications (77)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

A beta 42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Graph Chatbot

Chat with Graph Search

Hierarchical Protofilament Intertwining Rules the Formation of Mixed-Curvature Amyloid Polymorphs

Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records

Lewy body-associated proteins: Victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein

Following spatial A beta aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics

Half a century of amyloids: past, present and future

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity

Molecular dissection of amyloid disaggregation by human HSP70

Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives

A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of alpha-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in alpha-synuclein research

Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis